Robb Gary Charles
Chief Business Officer
Robb Gary Charles has filed 12 SEC Form 4 filings (30 transaction rows) across 1 company, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Sep 28, 2026.
On the most recent filing, Robb Gary Charles is listed as Chief Business Officer at CORCEPT THERAPEUTICS INC. Inside the rolling window, Robb Gary Charles reported no open-market purchases and 1 open-market sale totaling $1.2M in CORT.
Companies traded
Other insiders at CORT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Robb Gary Charles made?
Robb Gary Charles has filed 12 SEC Form 4 filings (30 transaction rows) across 1 company since 2025.
Which companies does Robb Gary Charles trade?
Robb Gary Charles has filed SEC Form 4 disclosures for 1 company, including CORT.
When was Robb Gary Charles's most recent SEC Form 4 filing?
Robb Gary Charles's most recent SEC Form 4 filing on Tracefour is dated Sep 28, 2026.
What is Robb Gary Charles's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Robb Gary Charles is listed as Chief Business Officer.
What is Robb Gary Charles's total buy and sell value in the current window?
Inside the rolling retention window, Robb Gary Charles bought $0 and sold $1.2M based on SEC Form 4 filings.
What was Robb Gary Charles's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 CORT shares on 2026-08-17, worth $1.2M, per SEC Form 4 filings.